Fundraising FoxKinnate Biopharma
San Diego, US · Founded 2018 · Delaware corporation · 7 known investors
Find your way into Kinnate Biopharma
Sign up to see every warm intro you have to Kinnate Biopharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kinnate Biopharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Kinnate Biopharma was founded in 2018 by Stephen W. Kaldor.
Board
Investors · 7
How we know: Foresite Capital's portfolio page · a partner's Signal profile · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Nextech Invest's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Viking Global's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$172.5M disclosed across 2 of 3 rounds · 2019–2021
▶$98MraisedAug 2020 · 24 investors · BiotechnologyRule 506(b)
- Keith FlahertyDirector
- Mark MeltzExecutive Officer
- Jim TananbaumDirector
- Dean MitchellDirector
- Stephen W. KaldorDirector, Promoter
- Carl GordonDirector
- Laurie Smaldone AlsupDirector
- Michael RomeDirector
- Nima FarzanExecutive Officer, Director
- Offering amount
- $98M
- Amount sold
- $98M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$74.5MraisedDec 2019 · 5 investors · PharmaceuticalsRule 506(b)
- Stephen W. KaldorExecutive Officer, Director, Promoter
- Eric MurphyExecutive Officer, Director
- Bret ZbarDirector
- Carl GordonDirector
- Michael RomeDirector
- Offering amount
- $74.5M
- Amount sold
- $74.5M
- First sale
- Dec 2019
- Incorporated
- Corporation, California, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Kinnate Biopharma?
- Kinnate Biopharma was founded by Stephen W. Kaldor in 2018.
- Who are Kinnate Biopharma's investors?
- Kinnate Biopharma's investors include Foresite Capital, Nextech Invest, Viking Global, Janus Henderson Investors, RA Capital, Venrock Healthcare Capital Partners, Viking Global Investors.
- How much funding has Kinnate Biopharma raised?
- Kinnate Biopharma has disclosed $172.5M raised across 2 of its 3 known rounds.
- Where is Kinnate Biopharma headquartered?
- Kinnate Biopharma is headquartered in San Diego, US.